1. Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation;Gosney;ESMO Open,2023
2. Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study;Lee;PLoS One,2018
3. Testing for EGFR mutations and ALK rearrangements in advanced non-small-cell lung cancer: considerations for countries in emerging markets;Dalurzo;Onco Targets Ther,2021
4. Clinical utility of rapid EGFR genotyping in advanced lung cancer;Dagogo-Jack;JCO Precis Oncol,2018